Zheng YB - Search Results

1

Dexamethasone enhances the antitumor efficacy of Gemcitabine by glucocorticoid receptor signaling.

Gong JH, Zheng YB, Zhang MR, Wang YX, Yang SQ, Wang RH, Miao QF, Liu XJ, Zhen YS. Gong JH, et al. Among authors: zheng yb. Cancer Biol Ther. 2020 Apr 2;21(4):332-343. doi: 10.1080/15384047.2019.1702399. Epub 2020 Jan 7. Cancer Biol Ther. 2020. PMID: 31906826 Free PMC article.

2

Factor VII light chain-targeted lidamycin targets tissue factor-overexpressing tumor cells for cancer therapy.

Zhang Q, Liu XJ, Hu L, Liao DS, Zheng YB, Zhen YS, Song X. Zhang Q, et al. Among authors: zheng yb. Int J Mol Med. 2012 Mar;29(3):409-15. doi: 10.3892/ijmm.2011.848. Epub 2011 Nov 22. Int J Mol Med. 2012. PMID: 22108624

3

An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity.

Zheng YB, Shang BY, Li Y, Zhen YS. Zheng YB, et al. Biomed Pharmacother. 2013 Mar;67(2):164-71. doi: 10.1016/j.biopha.2012.10.018. Epub 2012 Nov 19. Biomed Pharmacother. 2013. PMID: 23206754

4

[Inhibition of tumor cell invasion and induction of apoptosis by ubenimex].

Zheng YB, Gong JH, Li Y, Zhen YS. Zheng YB, et al. Yao Xue Xue Bao. 2012 Dec;47(12):1593-8. Yao Xue Xue Bao. 2012. PMID: 23460963 Chinese.

5

[Isolation and culture of mouse spermatogonial stem cells and determination of the related markers].

Zheng YB, Li Y, Zhen YS. Zheng YB, et al. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Jun;35(3):243-8. doi: 10.3881/j.issn.1000-503X.2013.03.001. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013. PMID: 23827059 Chinese.

6

Preparation and evaluation of a CD13/APN-targeting and hydrolase-resistant conjugate that comprises pingyangmycin and NGR motif-integrated apoprotein.

Li B, Zheng YB, Li DD, Zhen YS. Li B, et al. Among authors: zheng yb. J Pharm Sci. 2014 Apr;103(4):1204-13. doi: 10.1002/jps.23893. Epub 2014 Feb 6. J Pharm Sci. 2014. PMID: 24504597

7

A multifunctional drug combination shows highly potent therapeutic efficacy against human cancer xenografts in athymic mice.

Liu XJ, Zheng YB, Li Y, Wu SY, Zhen YS. Liu XJ, et al. Among authors: zheng yb. PLoS One. 2014 Dec 22;9(12):e115790. doi: 10.1371/journal.pone.0115790. eCollection 2014. PLoS One. 2014. PMID: 25531414 Free PMC article.

8

A Novel Nitrobenzoate Microtubule Inhibitor that Overcomes Multidrug Resistance Exhibits Antitumor Activity.

Zheng YB, Gong JH, Liu XJ, Wu SY, Li Y, Xu XD, Shang BY, Zhou JM, Zhu ZL, Si SY, Zhen YS. Zheng YB, et al. Sci Rep. 2016 Aug 11;6:31472. doi: 10.1038/srep31472. Sci Rep. 2016. PMID: 27510727 Free PMC article.

9

A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis.

Zheng YB, Gong JH, Liu XJ, Li Y, Zhen YS. Zheng YB, et al. Mol Carcinog. 2017 May;56(5):1395-1404. doi: 10.1002/mc.22600. Epub 2017 Jan 4. Mol Carcinog. 2017. PMID: 27991698

10

A new compound of thiophenylated pyridazinone IMB5043 showing potent antitumor efficacy through ATM-Chk2 pathway.

Gong J, Zheng Y, Wang Y, Sheng W, Li Y, Liu X, Si S, Shao R, Zhen Y. Gong J, et al. PLoS One. 2018 Feb 2;13(2):e0191984. doi: 10.1371/journal.pone.0191984. eCollection 2018. PLoS One. 2018. PMID: 29394294 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters